New Zealand King Salmon (NZK) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
29 Apr, 2026Executive summary
Net loss after tax of $6.3m for the 8 months to 30 September 2025, compared to a net profit of $13.4m for the 12 months to 31 January 2025, impacted by a shorter reporting period and challenging biological performance.
Pro-Forma EBITDA for the 8 months was $7.1m, down from $29.7m in the prior 12 months, reflecting reduced harvest and high operational leverage.
Capex spend was $12.5m, with $6.1m allocated to the Blue Endeavour pilot and $6.4m to ongoing business needs.
Balance sheet remains strong with net cash of $46.6m.
Blue Endeavour pilot progressing, though mooring grid completion delayed to March 2026.
Financial highlights
Revenue for the 8 months was $117.7m, down 44% from $211.0m in the prior 12 months, due to both a shorter period and reduced harvest.
Gross profit margin dropped to 9% from 22% year-over-year.
Pro-Forma EBITDA margin was 6% for the period, compared to 14% previously.
Net cash on hand decreased to $46.6m, reflecting lower profitability and ongoing investments.
Outlook and guidance
FY26 Pro-Forma EBITDA guidance: $9m–$15m; Pro-Forma EBIT guidance: ($3m) to $3m.
Expected harvest for FY26: 5,500–5,900 MT; Capex forecast: $28m–$36m.
Dividends remain on hold as capital is allocated to growth projects.
If a wellboat lease is secured, harvest volumes could rise to 7,200–7,600 MT in FY27 and 8,200–8,800 MT in FY28.
Latest events from New Zealand King Salmon
- $118M revenue, Blue Endeavour progress, and all board resolutions recommended.NZK
AGM 202618 Feb 2026 - Record revenue and EBITDA in FY25, but outlook lowered amid operational and climate challenges.NZK
AGM 20253 Feb 2026 - Pro-forma EBITDA up 26% to $13.5m; revenue rose 11% but net profit fell; no dividend declared.NZK
H1 202520 Jan 2026 - Record Pro Forma EBITDA of NZD 29.7m, but FY 2026 outlook cautious amid reduced harvest.NZK
H2 202526 Dec 2025 - Net loss of $20.8m on $94.5m revenue, but growth outlook remains strong amid biological risks.NZK
H1 202519 Dec 2025 - Strong FY24 results and strategic focus on sustainability set the stage for future growth.NZK
AGM 2024 Presentation13 Jun 2025